Adnan Ezzat

4.4k total citations · 1 hit paper
83 papers, 3.2k citations indexed

About

Adnan Ezzat is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Adnan Ezzat has authored 83 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 33 papers in Pathology and Forensic Medicine and 22 papers in Cancer Research. Recurrent topics in Adnan Ezzat's work include Lymphoma Diagnosis and Treatment (21 papers), Breast Cancer Treatment Studies (18 papers) and Viral-associated cancers and disorders (9 papers). Adnan Ezzat is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Breast Cancer Treatment Studies (18 papers) and Viral-associated cancers and disorders (9 papers). Adnan Ezzat collaborates with scholars based in Saudi Arabia, Germany and Canada. Adnan Ezzat's co-authors include A.Y. Rostom, Siema M. Bakheet, Ezzeldin M. Ibrahim, John Powe, Asma Tulbah, Dahish Ajarim, M.A. Raja, Fouad Al‐Dayel, Khawla S. Al‐Kuraya and Prashant Bavi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Adnan Ezzat

81 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

National Cancer Control Programmes, Policies and Managerial Guidelines

1996 783 citations Adnan Ezzat profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Adnan Ezzat	1.4k	722	667	653	548	83	3.2k
Deirdre A. Hill	1.3k 0.9×	647 0.9×	448 0.7×	474 0.7×	597 1.1×	85	3.3k
Daniel Rayson	2.0k 1.4×	452 0.6×	524 0.8×	379 0.6×	885 1.6×	137	3.4k
Claudia Allemani	2.3k 1.6×	801 1.1×	731 1.1×	571 0.9×	521 1.0×	84	4.3k
Victor R. Grann	2.7k 1.9×	934 1.3×	759 1.1×	361 0.6×	1.0k 1.8×	66	5.0k
Ingrid Glimelius	1.7k 1.2×	916 1.3×	638 1.0×	484 0.7×	270 0.5×	181	3.6k
Jeffrey Tobias	1.6k 1.1×	516 0.7×	1.0k 1.5×	379 0.6×	926 1.7×	136	3.7k
Jean Latreille	1.7k 1.3×	360 0.5×	558 0.8×	523 0.8×	805 1.5×	89	3.7k
Sercan Aksoy	1.7k 1.3×	334 0.5×	780 1.2×	403 0.6×	430 0.8×	284	3.6k
Ádám Gondos	1.9k 1.4×	629 0.9×	640 1.0×	610 0.9×	416 0.8×	80	3.9k
Mikael Hartman	1.6k 1.2×	447 0.6×	738 1.1×	333 0.5×	1.1k 2.1×	149	3.6k

Countries citing papers authored by Adnan Ezzat

Since Specialization

Citations

This map shows the geographic impact of Adnan Ezzat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Ezzat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Ezzat more than expected).

Fields of papers citing papers by Adnan Ezzat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adnan Ezzat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Ezzat. The network helps show where Adnan Ezzat may publish in the future.

Co-authorship network of co-authors of Adnan Ezzat

This figure shows the co-authorship network connecting the top 25 collaborators of Adnan Ezzat. A scholar is included among the top collaborators of Adnan Ezzat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adnan Ezzat. Adnan Ezzat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mourad, Walid A., Abdelghani Tbakhi, Yasser Khafaga, et al.. (2008). Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyterich large B-cell lymphoma and lymphocytepredominant Hodgkin lymphoma. Hematology/Oncology and Stem Cell Therapy. 1(1). 22–27. 4 indexed citations

Siraj, Abdul K., Muna Ibrahim, Maha Al‐Rasheed, et al.. (2007). Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Annals of Hematology. 86(12). 887–895. 15 indexed citations

Al‐Kuraya, Khawla S., Prashant Bavi, Adnan Ezzat, et al.. (2006). Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.. PubMed. 27(3). 323–8. 13 indexed citations

Tulbah, Asma, et al.. (2006). Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factors. Acta Oncologica. 45(2). 188–195. 99 indexed citations

Siraj, Abdul K., Prashant Bavi, Naif A. Al-Jomah, et al.. (2006). High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia. Modern Pathology. 19(8). 1124–1129. 5 indexed citations

Ezzat, Adnan, Ezzeldin M. Ibrahim, Dahish Ajarim, et al.. (2004). Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients. British Journal of Cancer. 90(5). 968–974. 33 indexed citations

Bazarbashi, Shouki, et al.. (2003). Phase II trial of cisplatin, 5-fluorouracil, and interferon-α-2B as first line treatment of advanced urothelial cancer. Urologic Oncology Seminars and Original Investigations. 21(3). 185–189. 2 indexed citations

Ibrahim, Ezzeldin M., et al.. (2002). HER-2/Neu Overexpression Does Not Predict Response to Neoadjuvant Chemotherapy or Prognosticate Survival in Patients with Locally Advanced Breast Cancer. Medical Oncology. 19(1). 15–24. 8 indexed citations

Allam, Ayman, Alaa Kandil, Gamal El-Husseiny, et al.. (2001). Primary Thyroid Lymphoma. American Journal of Clinical Oncology. 24(3). 299–305. 43 indexed citations

10.

Gortzak, E., Alberto Azzarelli, J. Buesa, et al.. (2001). A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma. European Journal of Cancer. 37(9). 1096–1103. 275 indexed citations

11.

Ackland, Stephen P., Antonio Antón, G. P. Breitbach, et al.. (2001). Dose-Intensive Epirubicin-Based Chemotherapy Is Superior to an Intensive Intravenous Cyclophosphamide, Methotrexate, and Fluorouracil Regimen in Metastatic Breast Cancer: A Randomized Multinational Study. Journal of Clinical Oncology. 19(4). 943–953. 48 indexed citations

12.

Ezzat, Adnan, Ezzeldin M. Ibrahim, Dahish Ajarim, et al.. (2000). High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin. Breast Cancer Research and Treatment. 62(3). 237–244. 19 indexed citations

13.

Ezzat, Adnan, et al.. (1999). Malignant Ovarian Germ Cell Tumours: A Survival and Prognostic Analysis. Acta Oncologica. 38(4). 455–460. 18 indexed citations

14.

Allam, Ayman, Gamal El-Husseiny, Yasser Khafaga, et al.. (1999). Ewing′s Sarcoma of the Head and Neck: A Retrospective Analysis of 24 Cases. Sarcoma. 3(1). 11–15. 63 indexed citations

15.

Khafaga, Yasser, Arif Jamshed, Ayman Allam, et al.. (1999). Stevens-Johnson Syndrome in Patients on Phenytoin and Cranial Radiotherapy. Acta Oncologica. 38(1). 111–116. 32 indexed citations

16.

Ibrahim, Ezzeldin M., Fatma A. Al-Mulhim, Ali Al Bshabshe, et al.. (1998). Breast cancer in the eastern province of Saudi Arabia. Medical Oncology. 15(4). 241–247. 39 indexed citations

17.

Ezzat, Adnan, et al.. (1997). A Prospective Study of VEC-POB and POCE Chemotherapy in Aggressive Non-Hodgkin's Lymphoma. American Journal of Clinical Oncology. 20(2). 179–183. 3 indexed citations

18.

Ezzat, Adnan, et al.. (1997). A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer. Annals of Oncology. 8(7). 663–667. 23 indexed citations

19.

Ezzat, Adnan, et al.. (1996). Frequency and distribution of 22,836 adult cancer cases referred to King Faisal Specialist Hospital and Research Centre.. PubMed. 16(2). 152–8. 17 indexed citations

20.

Bakri, Younes N., et al.. (1993). Liver Metastases of Gestational Trophoblastic Tumor. Gynecologic Oncology. 48(1). 110–113. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact